Relationship between radiation response and p53 status in human bladder cancer cells

References

• BIARD, D. S. F., MARTIN, M. L. E., RHUN, Y DUTHU, A., LEFAIX, J. L., MAY, E. and MAY, P., 1994, Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic develop-ment. Cancer Research, 54, 3361–3364.
   Google Scholar
• BRACHMAN, D. G., BECKETT, M., GRAVES, D., HARAF, D., VOICES, E. and WEICHSELBAU M, R. R., 1993, p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Research, 53, 3667–3669.
   PubMed Web of Science ®Google Scholar
• CAAMANO, J., RUGGERI, B., MOMIKI, S., SICKLER, A., ZHANG, S.Y. and KLEIN-SZANTO, A. J., 1991, Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma Cell lines. American Journal of Pathology, 139, 839–845.
   PubMed Web of Science ®Google Scholar
• CLARKE, A. R., GLEDHILL, S., HOOPER, M. L., BIRD, C. C. and WYLLIE, A. H., 1994, p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma—irradiation. oncogene, 9, 1767–1773.
   PubMed Web of Science ®Google Scholar
• ESRIG, D., SPRUCK, C. H., NICHOLS, P. W., CHAIWUN, B., STEVEN, K., GROSHEN, S., SKINNER, D. G., JONES, P. A. and Com, R.J., 1993, p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. American Journal of Pathology, 143, 1389–139.
   PubMed Web of Science ®Google Scholar
• FUJIMOTO, K., YAMADA, Y OKAJIMA, E., KAKIZOE, T., SASAKI, H. and SUGIMURA, T., 1992, Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Research, 52, 1393–1398.
   Google Scholar
• GANNON, J. V., GREAVES, R., Woo, R. and LANE, D. P., 1990, Activating mutations in p53 produce a common con-formational effect. A monoclonal antibody specific for the mutant form. The EMBO Journal, 9, 1595–1602.
   PubMed Web of Science ®Google Scholar
• GERWIN, B. J., SPILLARE, E., FORRESTER, K., LEHMAN, T.A., KISPERT, J., WELSH, J. A., PFEIFER, A. M. A., LECHNER, J. F., BAKER, S. J., VOGELSTEIN, B. and HARRIS C. C., 1992, Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their respons-iveness to a negative growth factor, transforming growth factor fit. Proceedings of the National Academy of Sciences, USA, 89, 2759–2763.
   Google Scholar
• GOUGH, N.M., 1988, Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Analytical Biochemistry, 173, 93–95.
   PubMed Web of Science ®Google Scholar
• GREENBLATT, M. S., BENNETT, W. P., HOLLSTEIN, M. and HARRIS, C. C., 1994, Mutations in the p53 tumor sup-pressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research, 54, 4855–4878.
   PubMed Web of Science ®Google Scholar
• HALL, P. A., MCKEE, P. H., MENAGE, H.D., DOVE RR. and LANE D. P., 1993, High levels of p53 protein in UV-irradiated normal human skin. oncogene, 8, 203–20.
   Google Scholar
• IsAAcs, W. B., CARTER, B. S. and EWING, C. M., 1991, Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Research, 51, 4716–4720.
   PubMed Web of Science ®Google Scholar
• JACKSON, P., Bos, E. and BRAITHWAITE, A. W., 1993, Wild-type mouse p53 down-regulates transcription from different virus enhancer/promoters. oncogene, 8, 589–597.
   PubMed Web of Science ®Google Scholar
• JACQUEMIER, J., MOLES, J. P., PENAULT-LLORCA, F., ADELAIDE, J., TORRENTE, M., VIENS, P., BIRNBAUM, D. and THEILLET, C., 1994, p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: com-parison of staining and PCR-SSCP results. British Journal of Cancer, 69, 846–852.
   Google Scholar
• KASTAN, M. B., ONYEKWERE, 0., SIDRANSKY, D., VOGELSTEIN,
   Google Scholar
• B. and CRAIG, R. W., 1991, Participation of p53 protein in the cellular response to DNA damage. Cancer Research, 51, 6304–6311.
   PubMed Web of Science ®Google Scholar
• KAWASHIMA, K., MIHARA, K., USUKI, H., SHIMIZU, N. and NAMBA, M., 1995, Transfected mutant p53 gene increases X-ray-induced cell killing and mutation in human fibroblasts immortalized with 4-nitroquinoline 1-oxide but does not induce neoplastic transformation of the cells. International J ournal of Cancer, 61, 76–79.
   PubMed Web of Science ®Google Scholar
• LEE, J.M. and BERNSTEIN, A., 1993, p53 mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Sciences, USA, 90, 5742–5746.
   PubMed Web of Science ®Google Scholar
• LEVINE, A. J., MOMAND, J. and FINLAY, C. A., 1991, The p53 tumour suppressor gene. Nature, 351, 453–456.
   PubMed Web of Science ®Google Scholar
• LICHER, A. S. and LAWRENCE, T. S., 1995, Medical progress: Recent advances in radiation oncology. The New England Journal of Medicine, 332, 371–379.
   PubMed Web of Science ®Google Scholar
• MADISEN, L, HOAR, D. I., HOLROYD, C. D., CRISP, M. and HODES, M. E., 1987, DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA. American Journal of Medical Genetics, 27, 379–390.
   PubMed Web of Science ®Google Scholar
• MCILWRATH, A. J., VASEY, P. A., Ross, G. M. and BROWN, R., 1994, Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radio-Sensitivity. Cancer Research, 54, 3718–3722.
   PubMed Web of Science ®Google Scholar
• MICHAEL-MICHALOVITZ, D., YEHIELY, F., GOTTLIEB, E. and OREN, M., 1991, Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding. Journal of Virology, 65, 4160 —4168.
   Web of Science ®Google Scholar
• NIGRO, J. M., BAKER, S. J., PREISINGER, A. C., JESSUP, J. M., HOSTETTER, R., CLEARY, K., BIGNER, S. H., DAVIDSON, N., BAYLIN, S. and DEVILLE, P., 1989, Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705–708.
   PubMed Web of Science ®Google Scholar
• O'CONNOR, P. M., JACKMAN, J., JONDLE, D., BHATIA, K., MAGRATH, I. and KOHN, K. W., 1993, Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensit-ivity of Burkitt's lymphoma cell lines. cancer Research, 53, 4776–4780.
   Google Scholar
• ORY, K., LEGROS, Y AUGUIN, C. and Soussi, T., 1994, Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. The EMBO Journal, 13, 3496–3504.
   Google Scholar
• REDDEL, R. R., KE, Y GERWIN, B. I., MCMENAMIN, M. G., LECHNER, J. F., Su, R. T., BRASH, D. E., PARK, J. B.,
   Google Scholar
• J. S. and HARRIS, C. C., 1988, Transformation of human bronchial epithelial cells by infection with 5V40 or adenovirus-12 5V40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid con-taining 5V40 early region genes. Cancer Research, 48, 1904–1909.
   PubMed Web of Science ®Google Scholar
• RIBEIRO, J. C. C., HANLEY, J. R. and RUSSELL, P. J., 1996, Studies of X-irradiated bladder cancer cell lines showing differences in p53 status: absence of a p53-dependent cell cycle checkpoint pathway. oncogene, 13, 1269–1278.
   Google Scholar
• RUSSELL, P. J. and GLAVES, D., 1997, Experimental models of bladder cancer. In Principles and Practice of Genitourinary Oncology edited by D. Raghavan, H. I. Scher, S. A. Leib el, and P. H. Lange, (Philadelphia: Lippincott-Raven Publishers), pp. 195–213.
   Google Scholar
• RUSSELL, P. J., JELBART, M., WILLS, E., SINGH, S., WASS, J., WOTHERSPOON, J. and RAGHAVAN, D., 1988, Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation. International J ournal of Cancer, 41, 74–82.
   PubMed Web of Science ®Google Scholar
• RUSSELL, P. J., PALAVIDIS, Z., ROZINOVA, E., PHILIPS, J., WILLS, E. J., LUKEIS, R., WASS, J. and RAGHAVAN, D., 1993, Characterization of a new human bladder cancer cell line, UCRU-BL-28. The Journal of Urology, 150, 1038–1044.
   PubMed Web of Science ®Google Scholar
• RUSSELL, P. J., WASS, J., LUKEIS, R., GARSON, 0. M., JELBART, M., WILLS, E., PHILIPS, J., BROWN, J., CARRINGTON, N. and VINCENT, P.C., 1989, Characterization of cell lines derived from a multiply aneuploid human bladder trans-itional-cell carcinoma, UCRU-BL-13. International Journal of Cancer, 44, 276–285.
   Google Scholar
• SIDRANSKY, D., VON ESCHENBACH, A., TSAI, Y. C., JONES, P., SUMMERHAYES, I., PAUL, M., GREEN, P., HAMILTON, S. R., FROST, P. and VOGELSTEIN, B., 1991, Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252, 706–709.
   PubMed Web of Science ®Google Scholar
• SLICHENMYER, W. J., NELSON, W. G., SLEBOS, R. J. and KASTAN, M. B., 1993, Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Research, 53, 4164–4168.
   PubMed Web of Science ®Google Scholar
• SMITH, M. L, CHEN, I. T., ZHAN, Q., O'CONNOR, P. M. and FORNACE, A.J. JR., 1995, Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. 0 ncogene, 10, 1053–1059.
   Google Scholar
• SUN, Y., NAKAMURA, K., WENDEL, E. D. and COLBURN, N.H., 1993a, Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma. Proceedings of the National Academy of Sciences, USA, 90, 2827–2831.
   PubMed Web of Science ®Google Scholar
• SUN, Y DONG, Z., NAKAMURA, K. and COLBURN, N. El, 1993b Dosage-dependent dominance over wild-type p53 of a mutant p53 isolated from nasopharyngeal carcinoma. The FASE B Journal, 7, 944–950.
   Google Scholar
• SYMONDS, H., KRALL, L., REMINGTON, L., SAENZ-ROBLES, M., LOWE, S. and JACKS, T., 1994, p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78, 703–711.
   Google Scholar
• VOJTESEK, B., BARTEK, J., MIDGLEY, C. A. and LANE, D. P., 1992, An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. Journal of Immunological Methods, 152, 237–244.
   PubMedGoogle Scholar
• WEST, C. M. L. and SUTHERLAND, R. 1\4.7 1986, A radiobiological comparison of human tumor soft-agar clonogenic assays. International journal of Cancer, 37, 897–903.
   Google Scholar
• Wu, J. K., YE, Z. and DARRAS, B. T., 1993, Sensitivity of single-strand conformation polymorphism (SSCP) analysis in detecting p53 point mutations in tumors with mixed cell populations. American Journal of Human Genetics, 52, 1273–1275.
   PubMed Web of Science ®Google Scholar
• XIA, F., WANG, Y.-H., TSANG, N.-M., YANDELL, D. W., KELSEY, K. T. and LIBER, H. L., 1995, Altered p53 status correlates with differences in sensitivity to radiation-induced muta-tion and apoptosis in two closely related human lymphob-last lines. Cancer Research, 55, 12–15.
   Google Scholar
• YEWDELL, J. W., GANNON, J. V. and LANE, D. P., 1986, Monoclonal antibody analysis of p53 expression in normal and transformed cells. Journal of Virology, 59, 444–452.
   PubMed Web of Science ®Google Scholar
• ZHAN, Q., BAE, I., KASTAN, M. B. and FORNACE, A. J. JR., 1994, The p53-dependent gamma-ray response of GADD45. Cancer Research, 54, 2755–2760.
   PubMed Web of Science ®Google Scholar